Ligand effects on the binding of cis- and trans-[PtCl2Am1Am2] to proteins

被引:43
作者
Najajreh, Y
Shulman, TP
Moshel, O
Farrell, N
Gibson, D
机构
[1] Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Sch Pharm, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Interdept Equip Unit, IL-91120 Jerusalem, Israel
[3] Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23284 USA
来源
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY | 2003年 / 8卷 / 1-2期
基金
美国国家科学基金会;
关键词
platinum complexes; protein binding; electrospray ionization mass spectrometry; ligand effects; kinetics;
D O I
10.1007/s00775-002-0402-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As part of a systematic study of the basic principles that govern the formation and reactivity of Pt-protein adducts, we report the effect of substituting the ammine ligand of cis- and trans-[PtCl2(NH3)(2)] complexes with bulkier planar aromatic or nonplanar cyclic amine ligands on the binding properties of the complexes to ubiquitin and to horse heart myoglobin. The ligand replacement had a different effect on the cis or trans isomers investigated. In the cis-Pt complexes, replacing one or both ammine ligands by piperidine or 4-picoline dramatically decreased the binding of the complexes to the proteins studied, whereas in the substituted trans-Pt complexes replacement of the ammine by a piperidine or 4-picoline increased the binding rate. This behavior may have to do with the different preferred binding sites of the cis- and trans-Pt complexes. The bulkier cis- or trans-Pt complexes investigated also did not display a preference for Metl of ubiquitin, possibly owing to steric constraints imposed by the substituted ligands. The introduction of a charged piperazine ligand significantly decreased the rate of binding to the protein, possibly owing to electrostatic interactions or hydrogen-bond formations with the surface of the protein. The binding of the complexes to ubiquitin and myoglobin does not disrupt the folding of the proteins as judged by electrospray ionization mass spectrometry.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 24 条
[1]  
Andrews P. A., 1994, ANTICANCER DRUG RESI, P217
[2]   Donor atom preferences in complexes of platinum and palladium with amino acids and related molecules [J].
Appleton, TG .
COORDINATION CHEMISTRY REVIEWS, 1997, 166 :313-359
[3]   STRUCTURAL AND FUNCTIONAL-CHANGES ASSOCIATED WITH MODIFICATION OF THE UBIQUITIN METHIONINE [J].
BAMEZAI, S ;
BANEZ, MAT ;
BRESLOW, E .
BIOCHEMISTRY, 1990, 29 (22) :5389-5396
[4]  
Basolo F., 1958, Mechanisms of Inorganic Reactions: A Study of Metal Complexes in Solution, V2nd
[5]  
DECONTI RC, 1973, CANCER RES, V33, P1310
[6]   SERUM-ALBUMIN AND OTHER PROGNOSTIC FACTORS RELATED TO RESPONSE AND SURVIVAL IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER [J].
ESPINOSA, E ;
FELIU, J ;
ZAMORA, P ;
BARON, MG ;
SANCHEZ, JJ ;
ORDONEZ, A ;
ESPINOSA, J .
LUNG CANCER, 1995, 12 (1-2) :67-76
[7]   A mass spectral study of the binding of the anticancer drug cisplatin to ubiquitin [J].
Gibson, D ;
Costello, CE .
EUROPEAN MASS SPECTROMETRY, 1999, 5 (06) :501-510
[8]   PHARMACOKINETICS AND PROTEIN-BINDING OF CIS-DICHLORODIAMMINE PLATINUM (II) ADMINISTERED AS A ONE-HOUR OR AS A 20-HOUR INFUSION [J].
GULLO, JJ ;
LITTERST, CL ;
MAGUIRE, PJ ;
SIKIC, BI ;
HOTH, DF ;
WOOLLEY, PV .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :21-26
[9]   PHASE-I TRIAL OF A CISPLATIN-ALBUMIN COMPLEX FOR THE TREATMENT OF CANCER OF THE HEAD AND NECK [J].
HOLDING, JD ;
LINDUP, WE ;
VANLAER, C ;
VREEBURG, GCM ;
SCHILLING, V ;
WILSON, JA ;
STELL, PM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (01) :75-81
[10]   HYDROGEN-DEUTERIUM EXCHANGE ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY - A METHOD FOR PROBING PROTEIN CONFORMATIONAL-CHANGES IN SOLUTION [J].
KATTA, V ;
CHAIT, BT .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (14) :6317-6321